We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$22.4B
AUM Growth
+$2.11B
Cap. Flow
+$775M
Cap. Flow %
3.46%
Top 10 Hldgs %
20.85%
Holding
3,349
New
266
Increased
1,598
Reduced
1,206
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 10.23%
2 Consumer Discretionary 4.98%
3 Financials 4.7%
4 Healthcare 3.82%
5 Communication Services 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEV
3276
DELISTED
The Lion Electric Company
LEV
-10,885
Closed -$137K
ROOF
3277
DELISTED
NYLI CBRE NextGen Real Estate ETF
ROOF
-50,954
Closed -$1.3M
DXYN
3278
DELISTED
Dixie Group Inc
DXYN
-13,550
Closed -$66K
FAM
3279
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
-11,261
Closed -$114K
MOON
3280
DELISTED
Direxion Moonshot Innovators ETF
MOON
-7,974
Closed -$255K
EVBG
3281
DELISTED
Everbridge, Inc. Common Stock
EVBG
-1,755
Closed -$265K
DMTK
3282
DELISTED
DermTech, Inc. Common Stock
DMTK
-7,892
Closed -$253K
FUV
3283
DELISTED
Arcimoto, Inc. Common Stock
FUV
-695
Closed -$159K
VIEW
3284
DELISTED
View, Inc. Class A Common Stock
VIEW
-286
Closed -$93K
POL
3285
DELISTED
Polished.com Inc.
POL
-508
Closed -$80K
THCX
3286
DELISTED
AXS Cannabis ETF
THCX
-1,143
Closed -$147K
RESP
3287
DELISTED
WisdomTree U.S. ESG Fund
RESP
-9,298
Closed -$435K
CHS
3288
DELISTED
Chicos FAS, Inc.
CHS
-11,973
Closed -$54K
RETA
3289
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-2,388
Closed -$240K
WWE
3290
DELISTED
World Wrestling Entertainment
WWE
-3,861
Closed -$217K
DMS
3291
DELISTED
Digital Media Solutions, Inc.
DMS
-1,535
Closed -$167K
IDEX
3292
DELISTED
Ideanomics, Inc. Common Stock
IDEX
-90
Closed -$22K
LABP
3293
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
-1,883
Closed -$275K
EWSC
3294
DELISTED
Invesco S&P SmallCap 600 Equal Weight ETF
EWSC
-15,454
Closed -$1.25M
POSH
3295
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
-12,310
Closed -$292K
LOTZ
3296
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
-13,601
Closed -$52K
RMO
3297
DELISTED
Romeo Power, Inc.
RMO
-13,472
Closed -$67K
EPZM
3298
DELISTED
Epizyme, Inc
EPZM
-12,500
Closed -$64K
MIC
3299
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
-5,113
Closed -$207K
WMC
3300
DELISTED
Western Asset Mortgage Capital Corporation
WMC
-1,173
Closed -$31K

Similar funds

Cambridge Investment Research Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Cambridge Investment Research Advisors held 3,349 positions worth $22.4B, up 10% from $20.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $775M of net new capital in Q4 2021, opening 266 new positions and adding to 1,598 existing holdings. Its largest new stake was CION Investment: 424,367 shares worth $5.55M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $19.5M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2021 buy was CION Investment: 424,367 shares worth $5.55M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q4 2021, an estimated $88.6M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $19.5M.
  • Cambridge Investment Research Advisors fully exited VEREIT, Inc. in Q4 2021, selling an estimated $5.14M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $22.4B portfolio in Q4 2021.
  • Cambridge Investment Research Advisors opened 266 new positions and closed 184 in Q4 2021.
  • Cambridge Investment Research Advisors's portfolio value rose 10% quarter-over-quarter to $22.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.